QCM
SANA icon

Quantinno Capital Management’s Sana Biotechnology SANA Stock Holding History

Quantinno Capital Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.1K Sell
16,083
-2,950
-15% -$9.5K ﹤0.01% 3409
2026
Q1 		$54.8K Buy
19,033
+2,322
+14% +$9.15K ﹤0.01% 3281
2025
Q4 		$68K Buy
+16,711
New +$74.8K ﹤0.01% 3138

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Quantinno Capital Management's SANA Position: Q2 2026 in Review

Quantinno Capital Management reduced its Sana Biotechnology (SANA) stake by 15% in Q2 2026, selling an estimated $9.5K and leaving 16,083 shares worth $56.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3409.

Quantinno Capital Management first reported a position in SANA in Q4 2025 and has held it in 3 quarters since. The position peaked at $68K in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Quantinno Capital Management held 16,083 shares of Sana Biotechnology worth $56.1K as of Q2 2026.
  • Quantinno Capital Management sold 2,950 Sana Biotechnology shares in Q2 2026, an estimated $9.5K.
  • Sana Biotechnology made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #3409 holding.
  • Quantinno Capital Management first reported a position in Sana Biotechnology in Q4 2025 and has held it in 3 quarters since.
  • Quantinno Capital Management's Sana Biotechnology position peaked at $68K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.